CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 174 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $17,818,000 | +423.0% | 1,136,367 | +251.5% | 0.05% | +440.0% |
| Q3 2015 | $3,407,000 | -92.3% | 323,274 | -81.6% | 0.01% | -91.5% |
| Q2 2015 | $44,196,000 | -31.9% | 1,752,424 | -24.7% | 0.12% | -28.7% |
| Q1 2015 | $64,854,000 | +33.1% | 2,327,028 | -12.8% | 0.16% | +32.3% |
| Q4 2014 | $48,724,000 | +139.9% | 2,669,796 | +70.4% | 0.12% | +143.1% |
| Q3 2014 | $20,311,000 | -63.1% | 1,567,233 | -53.6% | 0.05% | -19.0% |
| Q2 2014 | $55,078,000 | +566.1% | 3,374,928 | +621.2% | 0.06% | +231.6% |
| Q1 2014 | $8,269,000 | -66.3% | 467,952 | -53.8% | 0.02% | -65.5% |
| Q4 2013 | $24,539,000 | -54.8% | 1,013,570 | -33.9% | 0.06% | -56.0% |
| Q3 2013 | $54,306,000 | +88.3% | 1,532,763 | -17.0% | 0.12% | +86.6% |
| Q2 2013 | $28,841,000 | – | 1,847,569 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |